KR900700469A - 우레탄-보호된 아미노산-n-카르복시무수물 - Google Patents

우레탄-보호된 아미노산-n-카르복시무수물

Info

Publication number
KR900700469A
KR900700469A KR1019890702114A KR890702114A KR900700469A KR 900700469 A KR900700469 A KR 900700469A KR 1019890702114 A KR1019890702114 A KR 1019890702114A KR 890702114 A KR890702114 A KR 890702114A KR 900700469 A KR900700469 A KR 900700469A
Authority
KR
South Korea
Prior art keywords
urethane
amino acid
protected amino
carboxy anhydride
compounds
Prior art date
Application number
KR1019890702114A
Other languages
English (en)
Other versions
KR970002229B1 (ko
Inventor
윌리암 디. 풀러
미카엘 필립 코헨
프레드 알 나이더
머레이 구드멘
Original Assignee
바이오리서치, 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 바이오리서치, 인코포레이티드 filed Critical 바이오리서치, 인코포레이티드
Publication of KR900700469A publication Critical patent/KR900700469A/ko
Application granted granted Critical
Publication of KR970002229B1 publication Critical patent/KR970002229B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C07D263/26—Oxygen atoms attached in position 2 with hetero atoms or acyl radicals directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/44—Two oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/36—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/02—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution
    • C07K1/023—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution using racemisation inhibiting agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
  • Saccharide Compounds (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Polyethers (AREA)
KR1019890702114A 1988-03-11 1989-03-03 우레탄-보호된 아미노산-n-카르복시무수물 KR970002229B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US07/168,087 US4946942A (en) 1988-03-11 1988-03-11 Urethane-protected amino acid-N-carboxyanhydrides
PCT/US1989/000875 WO1989008643A1 (en) 1988-03-11 1989-03-03 Urethane-protected amino acid-n-carboxyanhydrides
US168,087 1989-03-11

Publications (2)

Publication Number Publication Date
KR900700469A true KR900700469A (ko) 1990-08-13
KR970002229B1 KR970002229B1 (ko) 1997-02-26

Family

ID=22610066

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019890702114A KR970002229B1 (ko) 1988-03-11 1989-03-03 우레탄-보호된 아미노산-n-카르복시무수물

Country Status (21)

Country Link
US (1) US4946942A (ko)
EP (1) EP0357750B1 (ko)
JP (1) JP2875834B2 (ko)
KR (1) KR970002229B1 (ko)
CN (1) CN1022412C (ko)
AT (1) ATE108438T1 (ko)
AU (1) AU616054B2 (ko)
CA (1) CA1321280C (ko)
CZ (1) CZ148989A3 (ko)
DD (1) DD280322A5 (ko)
DE (1) DE68916722T2 (ko)
FI (1) FI102379B (ko)
HK (1) HK1007744A1 (ko)
HU (1) HU205091B (ko)
IE (1) IE65149B1 (ko)
IL (1) IL89541A0 (ko)
NO (1) NO306304B1 (ko)
NZ (1) NZ228282A (ko)
PT (1) PT89961B (ko)
RU (1) RU2007396C1 (ko)
WO (1) WO1989008643A1 (ko)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5006661A (en) * 1987-06-16 1991-04-09 University Of Cincinnati Selective stereospecific biologically active beta-lactams
DE3839379A1 (de) * 1988-11-22 1990-05-23 Hoechst Ag Verfahren zur herstellung von tripeptiden
US6551784B2 (en) 1989-06-07 2003-04-22 Affymetrix Inc Method of comparing nucleic acid sequences
US5800992A (en) 1989-06-07 1998-09-01 Fodor; Stephen P.A. Method of detecting nucleic acids
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US5547839A (en) * 1989-06-07 1996-08-20 Affymax Technologies N.V. Sequencing of surface immobilized polymers utilizing microflourescence detection
US6406844B1 (en) 1989-06-07 2002-06-18 Affymetrix, Inc. Very large scale immobilized polymer synthesis
US5744101A (en) * 1989-06-07 1998-04-28 Affymax Technologies N.V. Photolabile nucleoside protecting groups
US6346413B1 (en) 1989-06-07 2002-02-12 Affymetrix, Inc. Polymer arrays
US5424186A (en) 1989-06-07 1995-06-13 Affymax Technologies N.V. Very large scale immobilized polymer synthesis
US6309822B1 (en) 1989-06-07 2001-10-30 Affymetrix, Inc. Method for comparing copy number of nucleic acid sequences
US6416952B1 (en) 1989-06-07 2002-07-09 Affymetrix, Inc. Photolithographic and other means for manufacturing arrays
US6506558B1 (en) 1990-03-07 2003-01-14 Affymetrix Inc. Very large scale immobilized polymer synthesis
DE69132843T2 (de) 1990-12-06 2002-09-12 Affymetrix Inc N D Ges D Staat Identifizierung von Nukleinsäuren in Proben
US6468740B1 (en) 1992-11-05 2002-10-22 Affymetrix, Inc. Cyclic and substituted immobilized molecular synthesis
TW306932B (ko) * 1993-08-27 1997-06-01 Holland Sweetener Co
US7625697B2 (en) * 1994-06-17 2009-12-01 The Board Of Trustees Of The Leland Stanford Junior University Methods for constructing subarrays and subarrays made thereby
US7378236B1 (en) 1994-06-17 2008-05-27 The Board Of Trustees Of The Leland Stanford Junior University Method for analyzing gene expression patterns
US7323298B1 (en) 1994-06-17 2008-01-29 The Board Of Trustees Of The Leland Stanford Junior University Microarray for determining the relative abundances of polynuceotide sequences
IN184759B (ko) * 1997-07-22 2000-09-23 Kaneka Corp
SI20211A (sl) 1998-07-21 2000-10-31 Kaneka Corporation Postopek za kristaliziranje maleatne soli N-(1(S)-etoksikarbonil-3-fenilpropil)-L-alanil-L-prolina
US6545264B1 (en) 1998-10-30 2003-04-08 Affymetrix, Inc. Systems and methods for high performance scanning
SE0000382D0 (sv) 2000-02-07 2000-02-07 Astrazeneca Ab New process
US6670447B2 (en) * 2000-07-04 2003-12-30 Mitsui Chemicals, Inc. Amino acid N-carboxyanhydrides with acyl substituents on nitrogen atoms thereof
DE10333368B4 (de) * 2003-07-23 2008-08-28 Universität Leipzig Oberflächenfunktionalisiertes Trägermaterial, Verfahren zu dessen Herstellung und dessen Verwendungen
FR2858976B1 (fr) * 2003-08-22 2006-02-10 Isochem Sa Procede d'obtention de n-carboxyanhydrides d'alpha-aminoacides a protection urethane
CN100575348C (zh) * 2004-10-26 2009-12-30 西格玛-奥尔德利希公司 氨基酸n-羧酸酐的合成
NZ569756A (en) 2005-12-12 2011-07-29 Allaccem Inc Methods and systems for preparing antimicrobial films and coatings utilising polycyclic bridged ammonium salts
NZ579785A (en) 2007-02-21 2012-06-29 Allaccem Inc Bridged polycyclic compound based compositions for the inhibition and amelioration of disease
WO2009017775A2 (en) * 2007-08-02 2009-02-05 Scinopharm Taiwan Ltd. Process for the preparation of a polypeptide
US8153617B2 (en) * 2007-08-10 2012-04-10 Allaccem, Inc. Bridged polycyclic compound based compositions for coating oral surfaces in humans
US8188068B2 (en) * 2007-08-10 2012-05-29 Allaccem, Inc. Bridged polycyclic compound based compositions for coating oral surfaces in pets
US8153618B2 (en) * 2007-08-10 2012-04-10 Allaccem, Inc. Bridged polycyclic compound based compositions for topical applications for pets
US20090074833A1 (en) * 2007-08-17 2009-03-19 Whiteford Jeffery A Bridged polycyclic compound based compositions for controlling bone resorption
FR2928372B1 (fr) * 2008-03-10 2010-12-31 Solvay Procede de synthese peptidique
US20100004218A1 (en) * 2008-06-20 2010-01-07 Whiteford Jeffery A Bridged polycyclic compound based compositions for renal therapy
US20100016270A1 (en) * 2008-06-20 2010-01-21 Whiteford Jeffery A Bridged polycyclic compound based compositions for controlling cholesterol levels
CA2827840C (en) * 2011-03-25 2016-11-08 Nippon Soda Co., Ltd. Glutamic acid benzyl ester n-carboxylic anhydride
CN107750247A (zh) * 2015-03-17 2018-03-02 里珍纳龙药品有限公司 氨基酸酰化试剂及其使用方法
JP6766432B2 (ja) * 2016-04-28 2020-10-14 Jsr株式会社 ポリアミノ酸の製造方法
KR102544146B1 (ko) * 2017-03-02 2023-06-15 가부시키가이샤 도우사 고가쿠 겐큐쇼 아미노산 중합체의 제조방법
CN112778236A (zh) * 2019-11-08 2021-05-11 华东理工大学 β、γ-氨基酸N-羧基硫代羰基环内酸酐单体的合成、聚合反应、聚合物制备及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1173562A (en) * 1966-04-25 1969-12-10 Pierrel Spa Chloramphenicol Ester Salts, the Preparation therof and Compositions Containing them
US4267344A (en) * 1972-09-22 1981-05-12 Proteinkemisk Institut. Tilknyttet Akademiet For De Tekniske Videnskaber N-Substituted N-carboxyanhydrides of α-amino acids and their application in the preparation of peptides
US4038411A (en) * 1973-09-25 1977-07-26 Merck & Co., Inc. Antihypertensive amino acid esters
US4038282A (en) * 1975-11-26 1977-07-26 Merck & Co., Inc. Pyridyl-4-methyl-succinimidocarbonate and process for its preparation
US4367234A (en) * 1980-07-28 1983-01-04 Pfizer Inc. Hypoglycemic 5-substituted oxazolidine-2,4-diones

Also Published As

Publication number Publication date
HUT52488A (en) 1990-07-28
NO894503L (no) 1989-11-10
RU2007396C1 (ru) 1994-02-15
DE68916722T2 (de) 1994-11-03
WO1989008643A1 (en) 1989-09-21
CN1022412C (zh) 1993-10-13
IE65149B1 (en) 1995-10-04
DD280322A5 (de) 1990-07-04
JP2875834B2 (ja) 1999-03-31
US4946942A (en) 1990-08-07
EP0357750B1 (en) 1994-07-13
NO894503D0 (no) 1989-11-10
HU205091B (en) 1992-03-30
NO306304B1 (no) 1999-10-18
CA1321280C (en) 1993-08-10
DE68916722D1 (de) 1994-08-18
EP0357750A1 (en) 1990-03-14
JPH02503923A (ja) 1990-11-15
PT89961A (pt) 1989-11-10
FI895382A0 (fi) 1989-11-10
EP0357750A4 (en) 1991-01-30
FI102379B1 (fi) 1998-11-30
PT89961B (pt) 1994-04-29
NZ228282A (en) 1990-10-26
FI102379B (fi) 1998-11-30
ATE108438T1 (de) 1994-07-15
AU4188789A (en) 1989-10-05
HK1007744A1 (en) 1999-04-23
CN1040793A (zh) 1990-03-28
HU891841D0 (en) 1990-04-28
KR970002229B1 (ko) 1997-02-26
IL89541A0 (en) 1989-09-10
CZ148989A3 (en) 1997-11-12
IE890778L (en) 1989-09-11
AU616054B2 (en) 1991-10-17

Similar Documents

Publication Publication Date Title
KR900700469A (ko) 우레탄-보호된 아미노산-n-카르복시무수물
NL300106I2 (nl) N-terminaal chemisch gemodificeerde eiwitpreparaten en werkwijzen.
DE69324487D1 (de) Rezeptorbindende region des diphtherietoxius
DE69333673D1 (de) Epitope von Stress Proteinen
DK614987A (da) Syntetiske htlv-iii peptider, praeparater og anvendelser deraf
FI944412A0 (fi) Proteiinin puhdistus
IT1163037B (it) Procedimento di sintesi di peptidi e agenti di bloccaggio di amminoacidi
DE68917837T2 (de) Peptid-Verbindungen.
HK1006674A1 (en) Synthetic peptides from streptococcal m protein and vaccines prepared therefrom
FI941749A0 (fi) Rekombinantti-Borrelia -proteiinien valmistus
NO894880L (no) Fremgangsmaate for fremstilling av antikoagulerende peptider.
DE69832299D1 (de) Einkettigen polypeptiden enthalten troponin i und troponin c
NO891926L (no) Fremgangsmaate for fremstilling av stabile protein- eller peptidpreparater.
ATE92078T1 (de) Pharmakologisch aktive peptide.
NO982227D0 (no) Urogenitalcarcinom-TPL komplekspeptider og antistoffer derav

Legal Events

Date Code Title Description
A201 Request for examination
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20080108

Year of fee payment: 11

LAPS Lapse due to unpaid annual fee